Glucos Viaflo Baxter

Glucos Viaflo Baxter is an intravenous glucose solution marketed in the European Union. The product contains the active ingredient glucose, supplied as a sterile solution for infusion. It is designed to provide a rapid source of carbohydrate for patients requiring energy support, such as those with low blood sugar or undergoing parenteral nutrition. The formulation is intended for use under medical supervision and is supplied in single-use containers.

Glucos Viaflo Baxter is used in clinical settings where a rapid carbohydrate source is needed.

- Management of acute hypoglycemia in hospitalized patients. - Supplementation during parenteral nutrition for patients unable to receive oral intake. - Support of energy metabolism during surgery or critical illness. - Dilution and administration of certain intravenous medications requiring a glucose carrier. - Provision of glucose in diagnostic procedures such as glucose tolerance testing when intravenous delivery is required. - Correction of electrolyte imbalances associated with low glucose levels.

Intravenous administration of glucose may be associated with a range of adverse effects, which are generally categorized as common or serious.

Common: - Transient hyperglycemia leading to elevated blood sugar levels. - Local irritation or pain at the infusion site. - Mild electrolyte shifts, particularly potassium changes. - Nausea or vomiting if administered rapidly. - Headache or dizziness. - Transient increase in serum osmolality.

Serious: - Severe hyperglycemia with risk of osmotic diuresis. - Hypersensitivity reactions, including rash or anaphylaxis. - Fluid overload in patients with compromised cardiac function. - Metabolic acidosis. - Pulmonary edema.

When using Glucos Viaflo Baxter, clinicians should observe several precautions to minimize risks and ensure appropriate patient monitoring.

- Verify blood glucose levels before and after infusion to avoid extreme hyper- or hypoglycemia. - Adjust infusion rate in patients with renal or cardiac insufficiency to prevent fluid overload. - Use aseptic technique to reduce risk of catheter-related infections. - Monitor electrolyte concentrations, especially potassium and sodium, during prolonged administration. - Consider contraindications such as known glucose intolerance or severe hyperglycemia. - Store the solution according to manufacturer guidelines to maintain sterility. - Assess for signs of allergic reaction during the first minutes of infusion. - Avoid use in patients receiving high-dose dextrose-containing medications without adjusting total carbohydrate load.

Glucose solutions can interact with other medications or clinical conditions, requiring careful consideration of concurrent therapies.

Avoid: - Co-administration with insulin without dose adjustment, which may cause severe hypoglycemia. - Simultaneous infusion of high-concentration potassium solutions, increasing risk of hyperkalemia. - Use with medications that contain dextrose in excess, leading to cumulative glucose overload. - Mixing with calcium‑containing solutions, which may precipitate.

Use with caution: - Concurrent use of diuretics that affect fluid balance; monitor for volume status. - Patients receiving corticosteroids, which can raise blood glucose; monitor levels closely. - Administration alongside contrast agents for imaging; observe for transient hyperglycemia. - Patients on beta‑blockers, as they may mask hypoglycemia symptoms. - Patients with severe liver disease; monitor glucose metabolism closely.